FMCQF News and Press, Fresenius Med Care Ag Ord From 07/14/23

2023-07-14 04:30:00 ET Summary Fiduciary Management, Inc. is an independent money management firm. FMI’s equity investing strategies apply a value discipline, with a focused approach firmly rooted in fundamental research. FMI’s Small Cap and International Strategies ...

2023-06-14 09:10:00 ET Summary US stocks ended May with solid gains and extended their strong performance into June, boosted by positive labor market data and the debt ceiling bill's progress. My investment activity in May picked up slightly from April, with net investments totali...

2023-05-09 16:11:02 ET Fresenius Medical Care AG & Co. KGaA (FMS) Q1 2023 Earnings Conference Call May 09, 2023 09:30 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chair, Chief Executive Officer & Acting Chief Financial Offi...

2023-03-11 07:47:55 ET Summary Invesco International Dividend Achievers ETF implements an international dividend growth strategy. The top sectors are utilities and financials, and the fund is overweight in Canadian companies. I compare it with another international ex-U.S. div...

2023-03-08 16:23:51 ET Summary In a recent article I suggested international stocks as an alternative while the cap-weighted S&P 500 completed a downward rerating of high-priced growth stocks. The Vanguard FTSE Europe ETF with little tech or overpriced growth might serve as a ...

2023-03-07 09:15:00 ET Summary Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets have started the new year with very solid gains following expectations about a more dovish Federal Reserve and a solid earnings season. My divi...

Fresenius Medical Care AG & Co. KGaA (FMS) Q4 2022 Earnings Conference Call February 22, 2023 09:30 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chair & Chief Executive Officer Conference Call Participants Graham Doyl...

The following slide deck was published by Fresenius Medical Care AG & Co. KGaA in conjunction with their 2022 Q4 earnings call. For further details see: Fresenius Medical Care AG & Co. KGaA 2022 Q4 - Results - Earnings Call Presentation

Summary It’s among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie. Several drugmakers are expected to begin offering biosimilar ver...

Summary Tweedy, Browne’s 13F portfolio value decreased from $2.27B to $1.88B this quarter. They increased Ionis Pharmaceuticals while reducing most of the other stakes. Berkshire Hathaway at ~20% of the portfolio is the largest position. This article is part of a se...